The IPO List
HomeListingsBlogsAboutJoin WhatsApp CommunityWhatsApp(Opens in a new tab)

The IPO List

Your trusted platform for IPO tracking and investment insights.

Quick Links

IPOsIPO ArchiveBlogsGMP AccuracyMethodologyAboutContact

Legal

Privacy PolicyTerms of ServiceDisclaimer

© 2026 The IPO List. All rights reserved.

  1. Home/
  2. IPO Calendar/
  3. Corona Remedies IPO
Corona Remedies
MainboardListed

Corona Remedies IPO

Bidding 8-10 Dec 2025, price band ₹1008–1062, lot 14 shares.

+38.42%
listing gain
OverviewGMPAllotment

Grey Market Premium Trend

₹342.5
Final GMP
38.42%
Actual Listing Gain
32.3%
GMP-Implied Gain
₹1008 - ₹1062
Price Band

GMP History

DateGMP (₹)Est. Listing Price (₹)Est. Listing Gain
14 Dec₹343₹1,40532.25%
13 Dec₹343₹1,40532.25%
12 Dec₹295₹1,35727.78%
11 Dec₹330₹1,39231.07%
10 Dec₹291₹1,35327.40%
9 Dec₹295₹1,35727.78%
8 Dec₹270₹1,33225.42%
7 Dec₹262₹1,32424.67%
6 Dec₹290₹1,35227.31%
5 Dec₹305₹1,36728.72%
4 Dec₹365₹1,42734.37%
3 Dec₹365₹1,42734.37%
2 Dec₹307₹1,36928.91%
1 Dec₹0₹1,0620.00%

IPO timeline

  1. Issue open date
    8 Dec 2025
  2. Issue close date
    10 Dec 2025
  3. UPI mandate deadline
    10 Dec 2025
  4. Allotment finalization
    11 Dec 2025
  5. Refund initiation
    12 Dec 2025
  6. Share credit
    12 Dec 2025
  7. Listing date
    15 Dec 2025
  8. Mandate end date
    25 Dec 2025
  9. Lock-in end date for anchor investors (50%)
    10 Jan 2026
  10. Lock-in end date for anchor investors (remaining)
    11 Mar 2026

Corona Remedies IPO Allotment Status

Allotment date:11 Dec 2025
Registrar:Bigshare Services
  1. Open the registrar's allotment page from the link below.
  2. Select Corona Remedies from the list of companies.
  3. Enter your PAN, application number or demat account (DP/Client ID).
  4. Submit to see how many shares you were allotted.
Check allotment on Bigshare Services(Opens in a new tab)BSE application status check(Opens in a new tab)

After allotment

Refund / mandate release:12 Dec 2025
Shares credited to demat:12 Dec 2025
Listing:15 Dec 2025
💸

IPO Subscription Status

CategoryTimesEst. Allotment Chances*
HNIs (Total)219.93🔥0.45%
bHNI246.67🔥0.41%
sHNI166.46🔥0.60%
QIBs293.8🔥-
Retail29.73🔥3.4%
Employees15.35🔥6.5%

*Rough estimate: 1 ÷ times subscribed. Retail and HNI allotment is by lottery, so actual odds depend on the number of applications.

Last updated: 10 December'25 04:43PM

Quick Stats

Issue Size:655cr
Lot Size:14 shares
Min Investment:₹14,868
P/E Ratio:43.47

Additional Resources

ProspectusRead(Opens in a new tab)

About the Company

Corona Remedies, founded in 2004 and headquartered in Ahmedabad, Gujarat, is a pharmaceutical company engaged in the research, manufacturing, and marketing of healthcare products. The company offers a range of products across multiple therapeutic areas, including women’s healthcare, cardio-diabetes, pain management, urology, and more. With two manufacturing facilities located in Gujarat and Himachal Pradesh, Corona Remedies has established a significant presence in the Indian pharmaceutical market. The company’s growth strategy includes organic expansion and strategic acquisitions, aiming to enhance its product portfolio and market reach. Corona Remedies continues to focus on delivering quality healthcare solutions to meet the evolving needs of patients.

Strengths

  • Consistent revenue growth with a CAGR of approximately 21% over the last three years.
  • Diversified product portfolio across multiple therapeutic areas.
  • Strong distribution network with a presence in urban and semi-urban areas.
  • Leadership positions in specific therapeutic segments, such as women’s healthcare and pain management.
  • EU-GMP and WHO-certified manufacturing facilities ensure high-quality production standards

Risks

  • High working capital intensity with a gross operating cycle exceeding 150 days.
  • Exposure to regulatory risks inherent in the pharmaceutical industry.
  • Dependence on contract manufacturing for certain products.
  • Ongoing capital expenditure projects with associated completion and cost risks.
  • Presence in a competitive and price-controlled domestic pharmaceutical market.

Corona Remedies IPO – Frequently Asked Questions

  • The price band for the Corona Remedies IPO is set at ₹1008 to ₹1062 per share.
  • The Corona Remedies IPO opens on December 8, 2025 and closes on December 10, 2025.
  • The tentative listing date for the Corona Remedies IPO is December 15, 2025.
  • The last recorded Grey Market Premium (GMP) for the Corona Remedies IPO before listing was ₹342.5 (32.25%). GMP is unofficial and is not a guarantee of the listing price.
  • The Corona Remedies IPO listed on December 15, 2025 with a listing gain of 38.42% over its issue price.
  • The Corona Remedies IPO allotment date is December 11, 2025. Once it is finalised, check your status with your PAN or application number on the website of the registrar, Bigshare Services. Issues listed on BSE can also be checked on the BSE application status page.
  • You can apply for the Corona Remedies IPO via your broker or bank using ASBA or UPI. Log in to your trading app (Zerodha, Upstox, Groww, etc.), select IPO section, choose Corona Remedies, enter lot quantity and UPI ID, then approve the mandate.
  • The lot size for the Corona Remedies IPO is 14 shares. Investors must apply for at least one lot (i.e., 14 shares), which costs ₹14,868 at the upper price band.

Related IPOs

Open and upcoming

  • Friends Union for Energising Lives (FUEL)Bidding 11-20 Nov 2026
    Open
  • Crystal Crop ProtectionBidding 18-20 Nov 2026
    Open
  • Mahanadi CoalfieldsBidding 19-23 Nov 2026
    Upcoming
  • Watrana RentalsBidding 19-23 Nov 2026
    Upcoming

Recent mainboard listings

  • Bombay Coated & Special SteelsListed 5 Nov 2026
    +10.98%
  • M.K.Sons Fine JewelsListed 4 Nov 2026
    +5.56%
  • BLS PolymersListed 3 Nov 2026
    +65.33%
  • SFC Environmental TechnologiesListed 3 Nov 2026
    +7.61%
  • EAAA India AlternativesListed 2 Nov 2026
    +0.63%
  • Jio PlatformsListed 28 Oct 2026
    +21.36%

All IPOs that opened in December 2025